Sonoma Pharmaceuticals, INC. (SNOA) SEC Filings — 2025

Filings

• Sonoma Pharma's Revenue Jumps, But Cash Drains Amidst Mounting Losses — 10-Q · Nov 4, 2025
• Sonoma Pharmaceuticals Reports Officer and Director Changes — 8-K · Oct 23, 2025
• Sonoma Pharmaceuticals Reports Director/Officer Changes & Financials — 8-K · Oct 9, 2025
• Sonoma Pharmaceuticals Files 8-K, Confirms Nasdaq Listing — 8-K · Sep 29, 2025
• Sonoma Pharmaceuticals Files 8-K — 8-K · Sep 26, 2025
• Sonoma Pharmaceuticals Files 8-K on Shareholder Votes — 8-K · Aug 29, 2025
• Sonoma Pharma's Q1 Revenue Dips 17%, Net Loss Widens — 10-Q · Aug 7, 2025
• Sonoma Pharma Details Executive Pay, Governance Ahead of Shareholder Vote — DEF 14A · Jul 11, 2025
• Sonoma Pharma's Sales Plunge 20% as Losses Mount to $10.5M — 10-K · Jun 17, 2025
• Sonoma Pharmaceuticals, INC. 8-K Filing — 8-K · Apr 28, 2025
• Sonoma Pharmaceuticals, INC. 8-K Filing — 8-K · Apr 7, 2025
• Sonoma Pharmaceuticals Enters Material Definitive Agreement — 8-K · Mar 25, 2025
• Sonoma Pharmaceuticals Files Q3 2025 10-Q — 10-Q · Feb 5, 2025
• Sonoma Pharmaceuticals Enters Material Definitive Agreement — 8-K · Jan 30, 2025
• Sonoma Pharmaceuticals Reports Director and Officer Changes — 8-K · Jan 3, 2025